Market Overview
When the center of the eyes’ cornea Is affected it may result in making the vision blur and sometimes the vision may be lost. This kind of situation can be termed macular degeneration. Macular degeneration is also popular by the name “age-related macular degeneration”(AMD). This problem occurs mainly in old-aged people. AMD is of two types- dry and wet. The disease has three stages- the early stage, intermediate stage, and final stage. When there is a growth of blood vessels under the macula, it results in leakage of blood and other fluids into the retina. This is the situation of wet AMD. In cases where the health of the center of the retina starts deteriorating, it is a case of dry AMD. There is no complete cure for this problem. However, preventive measures like consuming good nutritional food, regular exercise, and avoiding smoking have to be implemented. The increase in old-aged chronic patients drives the dry age-related macular degeneration (AMD) market towards growth.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/10657
Market Segmentation
The dry age-related macular degeneration (AMD) market can be segmented based on the stages, diagnosis, treatment involved, age group, applications, end-user, and region. According to the stages category, the market is further divided into early age-related macular degeneration, intermediate-age, and late-age macular degeneration. According to the age group, the market is divided into above 40 years, above 60 years, and above 75 years segments. According to the diagnosis, the market is divided into Preliminary tests, fluorescein angiogram, and optical coherence tomography. According to the treatment category, the market is divided into segments like nutrition therapy including zinc, vitamins and copper, and telescopic lens implant. According to the route of administration, the market is divided into injectables and oral administration. According to the end-user category, the market is divided into hospitals, diagnostic centers, academic research institutes, and clinics. According to the regional category, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the world.
Regional Classification
According to the stage category, the early stage of dry AMD contributes a maximum share to the market growth because of the increase in chronic patients. According to the age group, the age group above 75 years contributes more to the market growth. According to the treatment category, nutrition therapy contributes the maximum share while optical coherence tomography also known as OCT contributes the maximum to the market size. According to the administration of medicine, it is the oral administration of medicine that dominates the market. According to the end-user category, both hospitals and clinics dominate the market. According to the regional category, North America dominates the market.
Industry News
The global analysis of the dry age-related macular degeneration (AMD) market states that the market is expected to reach 15351.07 million US Dollars at an 8.20% CAGR by the end of 2027. The increase in chronic patients and increase in health care expenditure are some of the factors that result in dry age-related macular degeneration (AMD) market growth. The failure of the clinical trials failed in many cases and this became the hurdle in the market growth.
Browse Full Report: https://www.marketresearchfuture.com/reports/dry-age-related-macular-degeneration-amd-market-10657
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.